Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion study
Matthias Fischer, Lucas Moreno, David S Ziegler, Lynley V Marshall, C Michel Zwaan, Meredith S Irwin, Michela Casanova, Constantino Sabado, Beate Wulff, Mario Stegert, Luojun Wang, Felipe K Hurtado, Fabrice Branle, Birgit Geoerger, Johannes H Schulte
Topics & Concepts
MedicineCeritinibAnaplastic large-cell lymphomaLymphomaInternal medicineCancer researchPathologyOncologyPhases of clinical researchPhase (matter)DrugAnaplastic lymphoma kinaseLymphoma Diagnosis and TreatmentPharmaceutical studies and practicesCAR-T cell therapy research